Subject: Introdução à Medicina Long-term preventive effects of allergen specific immunotherapy: a systematic review and meta-analysis.

Slides:



Advertisements
Similar presentations
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Advertisements

Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Pharmacologic Treatment of Pediatric Headaches El-Chammas K, Keyes J, Thompson N,
Conducting systematic reviews for development of clinical guidelines 8 August 2013 Professor Mike Clarke
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
15 de Abril de A Meta-Analysis is a review in which bias has been reduced by the systematic identification, appraisal, synthesis and statistical.
Dr Narayana pradeep Consultant Pulmonologist Carewell hospital KasaragodKERALA.
1 A Meta-analysis on the Sensitivity and Specificity of Exhaled Nitric Oxide and Induced Sputum Eosinophilia for the Diagnosis of Asthma Introdução à Medicina.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2009.
Journal Club Alcohol and Health: Current Evidence January-February 2006.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
1 The Use of Exhaled Nitric Oxide and Induced Sputum Eosinophilia in the Diagnosis of Asthma – a systematic review – Introdução à Medicina 2006/2007 Class.
Journal Club Alcohol and Health: Current Evidence September–October 2004.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2010.
1 The Use of Inflammatory Biomarkers in the Diagnosis of Asthma – a systematic review – Introdução à Medicina 2006/2007 Class 3, First Year João Almeida.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2009.
Felix I. Zemel, MPH DrPH Student Tufts University School of Medicine.
C-Reactive Protein: a Prognosis Factor for Septic Patients Systematic Review and Meta-analysis Introduction to Medicine – 1 st Semester Class 4, First.
Agency for Healthcare Research and Quality (AHRQ)
Are the results valid? Was the validity of the included studies appraised?
Background Information : Projected prevalence of arthritis is expected to increase from 2.9 million to 6.5 million Canadians, a rise of 124% (Badley.
Progress with the literature reviews for the CHOICE programme Chris Dickens.
Reading Scientific Papers Shimae Soheilipour
Use of Multiple Allergen Mixes in Immunotherapy Harold S. Nelson, MD Professor of Medicine National Jewish Health University of Colorado Denver School.
Introdução à Medicina Faculdade de Medicina da Universidade do Porto Introdução à Medicina Home monitoring in respiratory chronic diseases: systematic.
Effects of Pediatric Asthma Education on Hospitalizations and Emergency Department Visits: A Meta-Analysis June 3, 2007 Janet M. Coffman, PhD, Michael.
Systematic Reviews.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
Allergy Symptom Response Following Conversion from Injection Immunotherapy to Sublingual Immunotherapy CDR Timothy Clenney, MD, MPH Naval Medical Center.
How to Analyze Systematic Reviews: practical session Akbar Soltani.MD. Tehran University of Medical Sciences (TUMS) Shariati Hospital
Evidence Based Medicine Meta-analysis and systematic reviews Ross Lawrenson.
SLIT: dealing with trouble, doing it right. Giovanni B Pajno MD Professor of Pediatrics Department of Pediatrics – Allergy Unit University of Messina Italy.
How to Analyze Therapy in the Medical Literature: practical session Akbar Soltani.MD. Tehran University of Medical Sciences (TUMS) Shariati Hospital
INTRODUCTION Upper respiratory tract infections, including acute pharyngitis, are common in general practice. Although the most common cause of pharyngitis.
Evidence-Based Medicine Presentation [Insert your name here] [Insert your designation here] [Insert your institutional affiliation here] Department of.
Clinical Writing for Interventional Cardiologists.
RevMan for Registrars Paul Glue, Psychological Medicine What is EBM? What is EBM? Different approaches/tools Different approaches/tools Systematic reviews.
Class 15, 1st year Introdução à Medicina II 28th May 2010
How to read a paper D. Singh-Ranger. Academic viva 2 papers 1 hour to read both Viva on both papers Summary-what is the paper about.
Wipanee Phupakdi, MD September 15, Overview  Define EBM  Learn steps in EBM process  Identify parts of a well-built clinical question  Discuss.
Objectives  Identify the key elements of a good randomised controlled study  To clarify the process of meta analysis and developing a systematic review.
Which Patients for Subcutaneous Immunotherapy? Harold S. Nelson. MD Professor of Medicine National Jewish Heath University of Colorado Denver School of.
Sifting through the evidence Sarah Fradsham. Types of Evidence Primary Literature Observational studies Case Report Case Series Case Control Study Cohort.
EBM --- Journal Reading Presenter :呂宥達 Date : 2005/10/27.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2012.
2012 實證醫學系統課程 第一組 報告 吳敏誠、鍾宜倫、凌久惠 2012/08/07. Acyclovir for treating primary herpetic gingivostomatitis(Review) Cochrane Library 2008, Issue 4.
بسم الله الرحمن الرحیم.
Chronic pelvic pain Journal Club 17 th June 2011 Dr Claire Hoxley (GPST1) Dr Harpreet Rayar (GPST2)
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2013.
A SYSTEMATIC REVIEW OF THE PREVENTIVE EFFECT OF ORAL HYGIENE ON PNEUMONIA AND RESPIRATORY TRACT INFECTION IN ELDERLY PEOPLE IN HOSPITALS AND NURSING HOMES:
LITERATURE REVIEW OF DECISION MODELS FOR DISEASES WITH SHORT-TERM FLUCTUATIONS/EPISODES: The Case of COPD Dr. Orpah Nasimiyu Wavomba
Sample Journal Club Your Name Here.
Immunotherapy for Allergic Rhinitis
Access to Epinephrine for Self-Administration (EPI Rph)
Systematic review of Present clinical reality
How to read a paper D. Singh-Ranger.
Supplementary Table 1. PRISMA checklist
Efficacy and safety of birch pollen immunotherapy for local allergic rhinitis  Andrzej Bożek, MD, PhD, Krzysztof Kołodziejczyk, MD, PhD, Jerzy Jarząb,
SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.
Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A meta-analysis–based comparison  Danilo Di.
SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.
House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies  Moisés A. Calderón, MD, PhD, Jörg Kleine-Tebbe, MD, Allan Linneberg,
Linda S. Cox, MD, Cheryl Hankin, PhD, Richard Lockey, MD 
Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial  Hendrik.
Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis  Stephen R. Durham,
Lack of Confidence Interval Reporting in Dermatology: A Call to Action
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years  Ronald Dahl, MD,
Presentation transcript:

Subject: Introdução à Medicina Long-term preventive effects of allergen specific immunotherapy: a systematic review and meta-analysis

Subject: Introdução à Medicina Regente da disciplina: Prof Dr. Altamiro da Costa Orientador: Dr. João Fonseca Azevedo L; Cardoso P; Coelho J; Gonçalves A; Maranhas M; Oliveira A; Pereira E; Pereira J; Silva V; Teixeira C;

Subject: Introdução à Medicina SUMMARY Introduction Objectives Participants and methods > Criteria Selection > Search Strategy Results > Identification and selection of the literature > Description of the included articles > Methodological quality assessment > Data extraction and analysis Preliminary Discussion References

Subject: Introdução à Medicina INTRODUCTION “Allergic diseases and asthma “have increased dramatically during the past 2 decades” 2 Today these diseases are very frequent; 2.7 million children in the United States suffer from asthma and over a hundred million people suffer from asthma, allergy and chronic obstructive pulmonary disease in Europe. 3 2.TePas EC, Umetsu DT. Immunotherapy of asthma and allergic diseases. California (USA): Department of Pediatrics, Stanford University; 2000 Dec; 12(6): Chin ES. Pediatrics, Reactive Airway Disease. Slapper D, Windle ML, Young GM, Halamka J, Bachur RG, editors. EMedicine from WebMD Nov.

Subject: Introdução à Medicina There is a chance that immunotherapy can prevent the evolution from rhinitis to asthma and the appearance of new sensitivities There is no systematic review proving its long-term efficacy on the prevention of new sensitivities and the evolution from rhinitis to asthma. HOWEVER…

Subject: Introdução à Medicina SIT group Control group Progression from rhinitis to asthma? New allergic sensitivities? End of the intervention During the studyFollow -up Patients with allergic diseases - Decrease symptoms; - Decrease medication. End of Follow-up Figure 1 – Graphic contextualising the problem of this systematic review.

Subject: Introdução à Medicina OBJECTIVES Search if allergen specific immunotherapy has long-term preventive effects after the treatment ceases Development of new sensitivities The evolution from rhinitis to asthma This has motivated us to make a systematic review, to investigate the veracity of this hypothesis

Subject: Introdução à Medicina To search PUBMED DATABASE Query: ("Immunotherapy"[MeSH Terms] OR "Immunotherapy"[All Fields] OR ("desensitization, immunologic"[MeSH Terms] OR "desensitization"[All Fields]) AND (("asthma"[MeSH Terms] OR "asthm*"[All Fields]) AND ("rhinitis"[MeSH Terms] AND "rhinitis"[All Fields]) OR ("airway diseases"[All Fields])) AND sensitive clinical query from PUBMED Search strategy

Subject: Introdução à Medicina Search strategy We also searched the references of the included studies and consult the review articles that already exist about the subject. 7, 9,13 Furthermore … 7.Cox L, Cohn JR. Duration of allergen immunotherapy in respiratory allergy: when is enough, enough?. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma & Immunology May; 98(5): Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. The Journal of Allergy and Clinical Immnunoly Apr;119(4): Calamita Z, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized- clinical trials using the Cochrane Collaboration method. Allergy Oct;61(10):

Subject: Introdução à Medicina PARTICIPANTS AND METHODS Article criteria selection Inclusion criteriaExclusion criteria

Subject: Introdução à Medicina Inclusion criteria Articles which refer to patients with allergic rhinitis or asthma treated with SIT; Studies with, at least, one year of follow-up after the treatment ceases; Articles reporting original data on the effects of immunotherapy on the: - progression from rhinitis to asthma ; - appearance of new allergic sensitivities; Controlled studies.

Subject: Introdução à Medicina Exclusion criteria Studies without a rigorous definition about the existence or not of asthma in the patients, at the beginning of the treatment; Studies that combine SIT with other types of treatment or medication; Studies in other language than the English.

Subject: Introdução à Medicina RESULTS

Subject: Introdução à Medicina Identification and selection of the literature 10 reports excluded - 9 without one year, at least, of follow-up - 1 not relative to patients suffering from asthma and/or rhinitis 14 electronically screened for detailed evaluation 392 excluded based on title/abstract 125 excluded - review articles 531 references identified electronically 4 reports included 3 articles included after consulting the references of review papers on this subject 7 studies included on the systematic review

Subject: Introdução à Medicina The articles were analyzed according to: Study identification: author, year, country Type of study; Study’s objective; Participants: number, age (children or adults), sex, health condition Interventions: use of SLIT or SCIT, type of allergen administrated Variables analysed: progression from rhinitis to asthma in patients treated with SIT and in group control, severity of the symptoms (if developed), development of new sensitivities in both patient groups, type of sensitivity developed (if developed), behaviour’s differences in both groups; Description of the included articles

Subject: Introdução à Medicina Type of treatment; Treatment duration; Follow-up duration; Control or placebo group; Time: seasonal, not-seasonal, co-seasonal; Results: development or not of asthma’s symptoms in patients with rhinitis that didn’t have asthma at the beginning of the study; appearance or not of new allergic sensitivities; development of other kinds of symptoms.

Subject: Introdução à Medicina  The participants of the included studies weren’t completely equals 4 studies > participants were children 3 Studies > participants were adults

Subject: Introdução à Medicina  In two of them (L. Jacobsen et al. and B. Niggmenn, et al.) Participants at the beginning suffered from rhinoconjunctivitis  In other four Participants initially had rhinitis and/or asthma  Eng PA, et al 2002 study Participants suffered from a sensitivity to grass pollen with or without tree pollen

Subject: Introdução à Medicina  Type of treatment administrated: L. Jacobsen et al. and B. Niggmenn, et al. Di Rienzo V, et al Three studies P. A. Eng et al SCIT: - Phleum pratense and Betula verrucosa SLITSCIT : - grass pollen allergen extracts Didn’t specify the type of SIT administrated.

Subject: Introdução à Medicina  Period of treatment duration: years  Period of follow – up: It ranged from 3 to 12 years

Subject: Introdução à Medicina Methodological quality assessment Delphi list D1Was a method of randomization performed? D2Was the treatment allocation concealed? D3Were the groups similar at baseline regarding the most important prognostic indicators? D4Were both inclusion and exclusion criteria specified? D5Was the outcome assessor blinded? D6Was the care provider blinded? D7Was the patient blinded? D8Were point estimates and measures of variability presented for the primary outcome measures? D9Did the analysis include an intention-to-treat analysis? D10Was the withdrawal/drop-out rate <20% of the total study population? D11Was the withdrawal/drop-out rate unlikely to cause bias? Table 1 – Items of the Delphi-list for the assessment of the methodological quality of the articles.

Subject: Introdução à Medicina Methodological quality assessment ArticleD1D2D3D4D5D6D7D8D9D10D11Total Delphi* L. Jacobsen, et al B. Niggemann, et al Pajno GB, et al Di Rienzo V, et al Eng, PA, et al Eng, PA, et al Durham SR., et al * Total Delphi (range 0-11): total score >/= 6 = high quality; <6 = low quality Table 2 - Results of the methodological quality assessment.

Subject: Introdução à Medicina Data extraction and analysis  DEVELOPMENT OF NEW SENSITIVITIES

Subject: Introdução à Medicina Data extraction and analysis  Pajno GB, et al % of the children in SIT group didn’t show any sensitization 33.3% in control group (p < )  Eng PA, et al % (8 out of 13) of the SIT patients developed a new sensitivity 100% (10 out of 10) in control group  Eng PA, et al the prevalence of sensitizations was: - 90% in the control group - 67% in the SIT group In comparison to a previous observation that has been made six years before none of the patients (control or SIT group) have developed new sensitizations in this period

Subject: Introdução à Medicina Data extraction and analysis  Stephen R. Durham, et al. decrease of late skin response to an allergen after the discontinuation of SIT >> No numbers or percentages

Subject: Introdução à Medicina Data extraction and analysis 0% Eng PA, et al %61%Eng PA, et al %25%Pajno GB, et al Control GroupSIT GroupStudy Table 3 - Results obtained by the included studies on the development of new sensitivities.

Subject: Introdução à Medicina Data extraction and analysis Figure 2 - Graphic of the results obtained by the included studies on the development of new sensitivities.

Subject: Introdução à Medicina Data extraction and analysis  DEVELOPMENT OF ASTHMA SYMPTONS

Subject: Introdução à Medicina Data extraction and analysis  Di Rienzo V, et al. 91% of the patients of SLIT group didn’t develop asthma 4% in the control group Increase of the number of patients with multiple sensitizations in SLIT group, in comparison with the control group.  L. Jacobsen, et al. 25% (16 out of 64) patients in SIT group developed asthma symptons 45% (24 out of 53) in control group  B. Niggemann, et al. 20% (15 out of 75) of the patients in SIT group evoluted from rhinitis to asthma 43% (29 out of 87) in control group

Subject: Introdução à Medicina Data extraction and analysis Table 4 - Results obtained by the included studies on the progression from rhinitis to asthma. 43%20% B. Niggemann, et al %25%L. Jacobsen, et al %9% Di Rienzo V, et al Control GroupSIT GroupStudy

Subject: Introdução à Medicina Data extraction and analysis Figure 3 - Graphic of the results obtained by the included studies on the progression from rhinitis to asthma.

Subject: Introdução à Medicina Data extraction and analysis DEVELOPMENT OF ASTHMA SYMPTONSDEVELOPMENT OF NEW SENSITIVITIES 2 trials: SIT is preventive 3 trials: SIT is preventive

Subject: Introdução à Medicina META – ANALYSIS: Figure 4 - Meta-analysis of development of asthma symptoms (all included studies on this subject): odds ratio (OR) with 95% confidence interval (CI) for each study and all studies combined (include test for heterogeneity).

Subject: Introdução à Medicina META – ANALYSIS: Figure 5 - Meta-analysis of development of asthma symptoms: odds ratio (OR) with 95% confidence interval (CI) for each study and all studies combined (include test for heterogeneity).

Subject: Introdução à Medicina META – ANALYSIS: Figure 6 - Meta-analysis of development of new sensitivities: odds ratio (OR) with 95% confidence interval (CI) for each study and all studies combined (include test for heterogeneity).

Subject: Introdução à Medicina Allergen specific immunotherapy reduces Symptoms of allergies Stop the progression from rhinitis to asthma Decrease the development of new sensitivities long after the treatment finished PRELIMINARY DISCUSSION

Subject: Introdução à Medicina REFERENCES 1. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database of Systematic Reviews. 2003; (4):CD TePas EC, Umetsu DT. Immunotherapy of asthma and allergic diseases. Current Opinion in Pediatrics Dec; 12(6): Chin ES. Pediatrics, Reactive Airway Disease. Slapper D, Windle ML, Young GM, Halamka J, Bachur RG, editors. EMedicine from WebMD Nov. 4. James T. Li, MD, PhD; Richard F. Lockey, MD; I. Leonard Bernstein, MD; Jay M. Portnoy, MD; and Richard A. Nicklas, MD, editors. Allergen immunotherapy: a practice parameter. The Journal of allergy and clinical immunology Jan; 90(1): O’Hehir RE, Sandrini A, Anderson GP, Rolland MJ. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation. Current Medicinal Chemistry. 2007;14(21): Greenberger PA, Ballow M, Casale TB, Platts-Mills TA, Sampson HA. Sublingual immunotherapy and subcutaneous immunotherapy: Issues in the United States. The Journal of Allergy and Clinical Immnunoly Oct 12; In Press, Corrected Proof.

Subject: Introdução à Medicina REFERENCES 7. Cox L, Cohn JR. Duration of allergen immunotherapy in respiratory allergy: when is enough, enough?. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma & Immunology May; 98(5): Malling HJ. Allergen-specific immune therapy in the treatment of asthma. Ugeskrift for Laeger Jan 24; 162(4): Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. The Journal of Allergy and Clinical Immnunoly Apr;119(4): Jacobsen L, Nuchel Petersen B, Wihl JAÊ, et al. Immunotherapy with partially purified and standardized tree pollen extracts. IV: Results from long-term (6-year) follow-up. Allergy. 1997; 52:914± Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children: a 14-year study. Pediatrics. 1968; 42:793±802.

Subject: Introdução à Medicina REFERENCES 12. Des Roches A, Paradis L, Menardo JL, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI: Specific immunotherapy prevents the onset of new sensitizations in children. The Journal of Allergy and Clinical Immnunoly. 1997; 99:450± Calamita Z, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy Oct;61(10):